CVM today
$1.31-$0.10 (-7.09%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourDescending Triangle
15 minLeaning Bullish
5 minStrong Bearish
Daily trend turns up above $1.64
Key levels
Resistance$1.72
Resistance$1.53
Support$1.24
Support$0.96
Latest news & SEC filings
ProductCEL-SCI shares Phase 3 Multikine data on pre-surgical use in head and neck cancer
NewsCEL SCI CEO acquires 100,000 shares at $1.38 average
All CVM news →About CEL-SCI
CEL-SCI is a clinical-stage biotechnology company that develops immunotherapies for cancer and other diseases. Its main product candidate, Multikine, is an investigational treatment for some head and neck tumors, while its LEAPS technology is being developed for rheumatoid arthritis. The company is based in the United States and has commercialization agreements for Multikine in Israel, Turkey, and Saudi Arabia.
Based on the company's 10-K filed Dec 29, 2025.
NYSE · Healthcare
CEL SCI CORP (CVM)
What Is the Price Target for CVM?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is CVM a Buy or Sell Right Now?
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for CVM.
Start Free Trial →Is CVM Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, PEG
Fair Value
$3.44
12
Moat Score
NONE
4/9
Piotroski Score
-29.0
Altman Z-Score
What Is Smart Money Doing with CVM?
Insider Signal
NEUTRAL
3 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
DISTRIBUTING
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| TALOR EYAL | officer | Buy | 1,165 | $2K | Sep 30, 2026 |
| PRICHEP PATRICIA B | officer | Buy | 2,082 | $4K | Sep 30, 2026 |
| KERSTEN GEERT R | director officer | Buy | 2,621 | $5K | Sep 30, 2026 |
| KERSTEN GEERT R | director officer | Buy | 300,000 | $360K | May 14, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →CVM Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
59.05%
FCF Growth YoY
9.3%
Revenue Trend
UNKNOWN
Dark Pool Trades for CVM
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for CVM, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:50:45 | $1.30 | 2,647 | $$3K | SELL |
| 19:36:44 | $1.31 | 2,000 | $$3K | BUY |
| 17:42:07 | $1.33 | 2,000 | $$3K | BUY |
| 16:17:50 | $1.35 | 1,000 | $$1K | BUY |
| 16:11:33 | $1.33 | 7,416 | $$10K | MIDPOINT |
5 dark pool trades shown · $$20K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for CEL SCI CORP (CVM) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →CVM — frequently asked questions
What is CVM stock price today?
CEL SCI CORP (CVM) is at $1.31, down 7.09% (-$0.10) at the Nov 11, 2026 close.
Why is CVM stock moving today?
Latest CVM news — Oct 26, 2026: CEL-SCI shares Phase 3 Multikine data on pre-surgical use in head and neck cancer · Aug 26, 2026: CEL SCI CEO acquires 100,000 shares at $1.38 average
What do analysts rate CVM?
Analyst ratings for CVM: 2 Buy, 0 Hold, 0 Sell — consensus Buy.
Did CVM beat earnings?
CVM last reported on Aug 13, 2026: EPS -$0.47.
Does CVM pay a dividend?
CVM does not currently pay a dividend.
What are CVM support and resistance levels?
Support: $1.24, $0.96. Resistance: $1.53, $1.72, $1.93.
What are insiders doing with CVM?
Insider activity: NEUTRAL, 3 buys and 0 sells in the last 90 days.
What is the latest news on CVM?
Oct 26, 2026: CEL-SCI shares Phase 3 Multikine data on pre-surgical use in head and neck cancer · Aug 26, 2026: CEL SCI CEO acquires 100,000 shares at $1.38 average